LyGenesis

LyGenesis, Inc. is a clinical-stage cell therapy company that transforms a patient’s lymph nodes into bioreactors capable of growing functioning ectopic organs. Their cell therapies target major unmet medical needs, including end-stage liver disease and type 1 diabetes.